Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. A pilot study
- Benlloch, M.
- Cuerda‐ballester, M.
- Drehmer, E.
- Platero, J.L.
- Carrera‐juliá, S.
- López‐rodríguez, M.M.
- Ceron, J.J.
- Tvarijonaviciute, A.
- Navarro, M.Á.
- Moreno, M.L.
- Ortí, J.E.L.R.
ISSN: 2072-6643
Année de publication: 2020
Volumen: 12
Número: 12
Pages: 1-14
Type: Article
